Disease burden of lung cancer attributable to metabolic and behavioral risks in China and globally from 1990 to 2021

被引:0
|
作者
Li, Lijun [1 ]
Zhang, Xiaoxin [1 ]
Jiang, Anqi [1 ]
Guo, Xiaotian [1 ]
Li, Guangrui [1 ]
Zhang, Minghui [1 ]
Pu, Haihong [1 ]
机构
[1] Harbin Med Univ, Canc Hosp, Dept Med Oncol, Harbin, Peoples R China
关键词
Lung cancer; Global disease burden; Metabolic risk; Behavioral risks; Bayesian age-period-cohort model;
D O I
10.1186/s12889-025-21941-y
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundThere are differences between China and globally in the burden of lung cancer attributed to behavioral and metabolic risks.MethodsThis research utilized the Global Burden of Disease (GBD) 2021 database to extract the deaths and disability-adjusted life-years (DALYs) of lung cancer attributed to metabolic and behavioral risks in China and globally, along with the age-standardized mortality rates (ASMR) and age-standardized DALYs rates (ASDR). The age-period-cohort model was used to identify age effects, period effects, cohort effects, as well as local and net drift. Decomposition analysis was used to quantify the relative contributions of aging, epidemiological change, and population to the lung cancer burden. Bayesian age-period-cohort model was used for predictive analysis.ResultsFrom 1990 to 2021, the ASMR of lung cancer attributed to smoking and secondhand smoke significantly decreased globally, but it increased slightly in China. And the ASMR of lung cancer attributed to diet low in fruits significantly decreased, while the ASMR due to high fasting plasma glucose increased both in China and globally. The net drifts of lung cancer deaths attributed to smoking and secondhand smoke were both negative values globally, while the net drifts were small and even close to zero in China. The net drifts attributed to diet low in fruits and high fasting plasma glucose globally were -2.06% and 0.29%, respectively, and the lung cancer deaths among elderly patients has been increasing annually. However, in China, the lung cancer deaths attributed to diet low in fruits has been decreasing annually across all age groups, while the deaths due to high fasting plasma glucose has been increasing year by year. In the next 15 years, the burden of lung cancer attributed to behavioral and metabolic risks was expected to decrease in China and globally, but the burden among Chinese women attributed to smoking and secondhand smoke showed a slow upward trend.ConclusionsOver the past thirty years, the global burden of lung cancer attributed to behavioral factors has decreased, while it increased slow in attribution to metabolic factors. In China, only the lung cancer burden attributed to diet low in fruits has decrease, others have exhibited a fluctuating trend. In the next 15 years, the burden of lung cancer attributed to behavioral and metabolic risks decreases globally, but the lung cancer burden attributed to smoking and secondhand smoke shows a slow upward trend among Chinese women. That asks a need for greater attention to the tobacco exposure among women.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] The global burden of disease attributable to metabolic risks in 204 countries and territories from 1990 to 2019
    Hu, Wanqin
    Zhai, Chunxia
    Sun, Hongyu
    Gong, XingYu
    Cui, Liangyu
    Cai, Lin
    Zong, Qiqun
    Yu, Guanghui
    Wang, Fang
    Zou, Yanfeng
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 196
  • [2] Global burden of common cancers attributable to metabolic risks from 1990 to 2019
    Xing, Qing-Qing
    Li, Jing-Mao
    Chen, Zhi-Jian
    Lin, Xiao-Yu
    You, Yan-Yin
    Hong, Mei-Zhu
    Weng, Shangeng
    Pan, Jin-Shui
    MED, 2023, 4 (03): : 168 - +
  • [3] National and provincial burden of lung cancer attributable to fine particulate matter air pollution in China, 1990-2021: a systematic analysis of the Global Burden of Disease Study 2021
    Jiang, Yixuan
    Yin, Peng
    Chen, Renjie
    Kan, Haidong
    Zhou, Maigeng
    LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2025, 55 : 93 - 94
  • [4] Burden of Lung Cancer Attributable to Occupational Carcinogens from 1990 to 2019 and Projections until 2044 in China
    Fan, Yaguang
    Jiang, Yong
    Li, Xin
    Li, Xuebing
    Li, Yang
    Wu, Heng
    Pan, Hongli
    Wang, Ying
    Meng, Zhaowei
    Zhou, Qinghua
    Qiao, Youlin
    CANCERS, 2022, 14 (16)
  • [5] Burden of lung cancer along with attributable risk factors in China from 1990 to 2019, and projections until 2030
    Yuan Fang
    Zhen Li
    Hui Chen
    Tongchao Zhang
    Xiaolin Yin
    Jinyu Man
    Xiaorong Yang
    Ming Lu
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 3209 - 3218
  • [6] Burden of lung cancer along with attributable risk factors in China from 1990 to 2019, and projections until 2030
    Fang, Yuan
    Li, Zhen
    Chen, Hui
    Zhang, Tongchao
    Yin, Xiaolin
    Man, Jinyu
    Yang, Xiaorong
    Lu, Ming
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (07) : 3209 - 3218
  • [7] The Burden of Trachea, Bronchus, and Lung Cancer Attributable to Occupational Exposure From 1990 to 2019
    Li, Haifeng
    Guo, Jingwen
    Liang, Hongsen
    Zhang, Ting
    Zhang, Jinyu
    Wei, Li
    Shi, Donglei
    Zhang, Junhang
    Wang, Zhaojun
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [8] Burden of Lung Cancer in China, 1990-2019: Findings from the Global Burden of Disease Study 2019
    Sun, Huixin
    Zhang, Haiyu
    Cai, Huilong
    Yuan, Weiguang
    Wang, Fengjiao
    Jiang, Yang
    Gu, Xinyue
    Kang, Ziman
    Kang, Yue
    CANCER CONTROL, 2023, 30
  • [9] The disease burden attributable to 18 occupational risks in China: an analysis for the global burden of disease study 2017
    Li, Jie
    Yin, Peng
    Wang, Haidong
    Zeng, Xinying
    Zhang, Xiao
    Wang, Lijun
    Liu, Jiangmei
    Liu, Yunning
    You, Jinling
    Zhao, Zhenping
    Yu, Shicheng
    Zhou, Maigeng
    ENVIRONMENTAL HEALTH, 2020, 19 (01)
  • [10] Global burden of lung cancer in women of childbearing age attributable to ambient particulate matter pollution: 1990-2021
    Song, Ying-da
    Wang, Ruizhe
    Wang, Jia-xuan
    Tan, Xun-wu
    Ma, Jun
    CANCER MEDICINE, 2024, 13 (18):